Want to see IN:VALIANTORG full AI Analyst Report?
Top Page
Valiant Organics Limited
(VALIANTORG)
Select Model
Select Model
Rating:58Neutral
Price Target:
₹475.00
▲(69.64% Upside)
Action:Reiterated
Date:10/01/26
The score is anchored by improving but still inconsistent fundamentals (recovering earnings and positive cash flow, but multi-year revenue decline and high margin/FCF volatility). Technicals are supportive due to a strong uptrend above key moving averages, though momentum is overheated (RSI>70), and valuation appears only moderate (P/E 23.59) without dividend support.
Positive Factors
Profitability Recovery
The return to positive net income and improved operating profitability indicates that the business has recovered from its recent weakest period. If maintained, this provides a stronger base for reinvestment, customer support, and earnings rebuilding over the next several quarters.
Negative Factors
Multi-Year Revenue Decline
Several years of declining revenue weaken confidence in sustained demand growth across the company’s agrochemical, pharmaceutical, and industrial customer base. Continued contraction could reduce plant utilization, limit operating leverage, and make the recent profitability recovery harder to sustain.
Read all positive and negative factors
Positive Factors
Negative Factors
Profitability Recovery
The return to positive net income and improved operating profitability indicates that the business has recovered from its recent weakest period. If maintained, this provides a stronger base for reinvestment, customer support, and earnings rebuilding over the next several quarters.
Read all positive factors
Valiant Organics Limited (VALIANTORG) vs. iShares MSCI India ETF (INDA)
Market Cap
₹13.41B
Dividend Yield0.99%
Average Volume (3M)4.64K
Price to Earnings (P/E)24.4
Beta (1Y)0.68
Revenue Growth1.41%
EPS Growth946.41%
CountryIN
Employees908
SectorGeneral
Sector StrengthN/A
IndustryChemicals
Share Statistics
EPS (TTM)19.29
Shares Outstanding28,034,610
10 Day Avg. Volume7,761
30 Day Avg. Volume4,639
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)0.75
Price to Sales (P/S)0.77
P/FCF Ratio12.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Valiant Organics Limited Business Overview & Revenue Model
Company Description
Founded in Mumbai, India, in 1984, Valiant Organics Limited operates as a chemical manufacturer, specializing in the production and distribution of specialty chemicals across India. Their diverse product portfolio encompasses a variety of chloroph...
How the Company Makes Money
Valiant Organics primarily makes money by manufacturing specialty chemical intermediates and selling them to business customers (B2B), including agrochemical, pharmaceutical, and other industrial chemical companies. Revenue is largely generated fr...
Valiant Organics Limited Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
64
Positive
Cash Flow
52
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.66B | 7.39B | 7.19B | 7.23B | 10.52B | 11.53B |
| Gross Profit | 2.30B | 2.13B | 2.62B | 470.01M | 1.81B | 2.17B |
| EBITDA | 1.05B | 996.99M | 615.51M | 425.75M | 1.77B | 2.12B |
| Net Income | 540.85M | 332.36M | -37.36M | -83.91M | 881.21M | 1.13B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 12.31B | 11.83B | 12.48B | 12.39B | 11.92B |
| Cash, Cash Equivalents and Short-Term Investments | 21.43M | 21.24M | 131.53M | 71.02M | 456.71M | 499.47M |
| Total Debt | 0.00 | 2.56B | 2.49B | 2.57B | 2.74B | 3.63B |
| Total Liabilities | -7.59B | 4.71B | 4.58B | 5.19B | 4.99B | 5.43B |
| Stockholders Equity | 7.59B | 7.59B | 7.25B | 7.29B | 6.89B | 6.13B |
Cash Flow | ||||||
| Free Cash Flow | 797.52M | 439.27M | 256.03M | 90.70M | 862.19M | -1.53B |
| Operating Cash Flow | 922.42M | 774.59M | 564.32M | 840.00M | 2.38B | -307.47M |
| Investing Cash Flow | -702.45M | -898.89M | -209.61M | -649.88M | -1.43B | -1.24B |
| Financing Cash Flow | -230.76M | 71.27M | -318.13M | -231.19M | -1.12B | 1.67B |
Valiant Organics Limited Technical Analysis
Positive
280.00
Price Trends
333.88
Positive
308.69
Positive
281.34
Positive
Market Momentum
33.10
Negative
79.11
Negative
73.82
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VALIANTORG, the sentiment is Positive. The current price of 280 is below the 20-day moving average (MA) of 392.88, below the 50-day MA of 333.88, and below the 200-day MA of 281.34, indicating a bullish trend. The MACD of 33.10 indicates Negative momentum. The RSI at 79.11 is Negative, neither overbought nor oversold. The STOCH value of 73.82 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:VALIANTORG.
Valiant Organics Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | ₹12.62B | 19.50 | ― | 0.29% | 8.15% | 41.80% | |
65 Neutral | ₹417.30B | 52.78 | ― | 0.19% | 42.43% | 115.65% | |
64 Neutral | ₹20.01B | 6.05 | ― | 0.87% | 12.01% | 23.71% | |
61 Neutral | ₹9.90B | 12.30 | ― | 0.37% | 13.23% | 22.22% | |
58 Neutral | ₹13.41B | 24.37 | ― | 0.99% | 1.41% | 946.41% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
54 Neutral | ₹203.73B | 25.98 | ― | 0.50% | 8.20% | 29.06% |
* General Sector Average
IN:VALIANTORG
Valiant Organics Limited
478.35
139.40
41.13%
IN:DEEPAKNTR
Deepak Nitrite Limited
1,493.70
-349.83
-18.98%
IN:INDIAGLYCO
India Glycols Limited
298.60
109.20
57.65%
IN:INDOAMIN
Indo Amines Limited
136.35
-1.89
-1.37%
IN:NAVINFLUOR
Navin Fluorine International Limited
8,133.05
3,547.86
77.38%
IN:PUNJABCHEM
Punjab Chemicals & Crop Protection Ltd.
1,029.30
-281.31
-21.46%
Valiant Organics Limited Corporate Events
Valiant Organics posts Q1 FY27 results, renews MD and shifts registered office
Aug 12, 2026
Valiant Organics Limited’s board has approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, following audit committee review, and will publish these figures in accordance with securities regulat...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.